Louise Bjerregaard (@Bjerregaard91) profile picture

•MD, PhD •Postdoctoral Research Fellow at Beth Israel Deaconess Medical Center and Harvard Medical School

Boston, MA
Joined August 2022
Photo by Louise Bjerregaard (@Bjerregaard91)
Honored to join the podcast “In the Thick of It” by the Hypertrophic Cardiomyopathy Society to discuss our recent work on beta blockers and calcium channel blockers in non-obstructive HCM. #HCM #hcmsociety
Beta Blockers:New Evidence in Non-Obstructive HCM Care. The latest episode of “In the Thick of It,”an HCMS podcast sponsored by Cytokinetics.Essential for those moving beyond expert opinion to evidence-based, personalized care bit.ly/4f0lGJp #hcmpodcast #HCM #hcmsociety
57
Appreciate the comments - glad to see our study sparking discussion 🫀
I realize beta-blockers have not been shown beneficial in non-obstructive HCM, but, they are commonly prescribed here and in HFpEF. I like this study. It shows clearly that BB worsen exercise capacity. BB have very selective indications. I am not sure why they are popular
71
Our RCT comparing bisoprolol and verapamil in non-obstructive HCM is now published in #JACC ✨ - Bisoprolol: ↓ pVO₂, ↑ NT-proBNP & ↓ KCCQ - Verapamil: No change in pVO₂ & KCCQ, ↓ NT-proBNP 🔗authors.elsevier.com/a/1miXb… #HCM #Clinicaltrial
50
In obstructive #HCM, #pVO2, #NYHA, and #KCCQ don’t always align! Weak correlations and frequent patient-level discordance raise considerations for optimal metric selection in clinical practice and clinical trial design. 🔗kwnsfk27.r.eu-west-1.awstrac…
2
1
143
Thank you @DCAcademyDK for an amazing #dcasummermeeting23 ☀️ We already look forward to next year’s meeting 🫀
4
7
34
1,582